4.1(top 10%)
impact factor
1.4K(top 20%)
papers
22.8K(top 10%)
citations
60(top 10%)
h-index
4.3(top 10%)
impact factor
1.5K
all documents
25.1K
doc citations
95(top 10%)
g-index
Top Articles
| # | Title | Journal | Year | Citations |
|---|---|---|---|---|
| 1 | Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients? | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 459 |
| 2 | The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 375 |
| 3 | Managing Immune Checkpoint-Blocking Antibody Side Effects | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2015 | 344 |
| 4 | Implementation of Patient-Reported Outcomes in Routine Medical Care | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 260 |
| 5 | Telemedicine in Cancer Care | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 253 |
| 6 | The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 246 |
| 7 | Biomarker Testing for Patients With Advanced Non–Small Cell Lung Cancer: Real-World Issues and Tough Choices | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 210 |
| 8 | The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 200 |
| 9 | Updated Diagnostic Criteria and Staging System for Multiple Myeloma | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 199 |
| 10 | Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 196 |
| 11 | Patterns of Response and Progression to Immunotherapy | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 196 |
| 12 | Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 173 |
| 13 | Early Detection of Cancer: Past, Present, and Future | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2015 | 161 |
| 14 | Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 160 |
| 15 | Tumor Boards: Optimizing the Structure and Improving Efficiency of Multidisciplinary Management of Patients with Cancer Worldwide | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 156 |
| 16 | Precision Oncology: Who, How, What, When, and When Not? | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2017 | 151 |
| 17 | The DNA Damaging Revolution: PARP Inhibitors and Beyond | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 144 |
| 18 | National Cancer Institute's Precision Medicine Initiatives for the New National Clinical Trials Network | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 141 |
| 19 | Overcoming Barriers to Clinical Trial Enrollment | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 130 |
| 20 | The Rising Incidence of Second Cancers: Patterns of Occurrence and Identification of Risk Factors for Children and Adults | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 129 |
| 21 | Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 126 |
| 22 | Risk Stratification for Wilms Tumor: Current Approach and Future Directions | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 124 |
| 23 | Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 123 |
| 24 | Basic Overview of Current Immunotherapy Approaches in Cancer | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 115 |
| 25 | Accelerated Aging among Cancer Survivors: From Pediatrics to Geriatrics | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 109 |
| 26 | Triple-Negative Breast Cancer: Molecular Subtypes and New Targets for Therapy | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2015 | 108 |
| 27 | Genomic Alteration in Metastatic Breast Cancer and Its Treatment | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2020 | 107 |
| 28 | Tobacco and Lung Cancer: Risks, Trends, and Outcomes in Patients with Cancer | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2013 | 104 |
| 29 | Obesity and Inflammation: New Insights into Breast Cancer Development and Progression | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2013 | 102 |
| 30 | ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection? | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2015 | 102 |
| 31 | Colorectal Cancer in the Young: Epidemiology, Prevention, Management | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2020 | 101 |
| 32 | Nutritional Supplements and Cancer: Potential Benefits and Proven Harms | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 98 |
| 33 | Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 96 |
| 34 | Triple-Negative Breast Cancer: Immune Modulation as the New Treatment Paradigm | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2015 | 93 |
| 35 | The Value and Future Developments of Multidisciplinary Team Cancer Care | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 93 |
| 36 | 50 Years of Progress in the Systemic Therapy of Non–Small Cell Lung Cancer | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 92 |
| 37 | Updated Diagnostic Criteria and Staging System for Multiple Myeloma | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 92 |
| 38 | Endometrial Cancer: Is This a New Disease? | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2017 | 91 |
| 39 | Obesity and Inflammation: New Insights into Breast Cancer Development and Progression | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2013 | 89 |
| 40 | The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 85 |
| 41 | Biomarkers for Immunotherapy: Current Developments and Challenges | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 85 |
| 42 | Cancer Pain Management: Safe and Effective Use of Opioids | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2015 | 84 |
| 43 | Predicting and Preventing Anthracycline-Related Cardiotoxicity | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 84 |
| 44 | New and Important Changes in the TNM Staging System for Breast Cancer | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 83 |
| 45 | Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2016 | 81 |
| 46 | Cognitive Changes in Cancer Survivors | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2018 | 79 |
| 47 | The Future of Wearable Technologies and Remote Monitoring in Health Care | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2019 | 79 |
| 48 | Barriers and Facilitators to Telemedicine: Can You Hear Me Now? | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2021 | 79 |
| 49 | Ampullary Cancer: An Overview | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 78 |
| 50 | Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations | American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting | 2014 | 75 |